2.3. Isolation, culture and treatment of human atrial fibroblasts (HAFs)

ZY Zhenzhen Yang
ZX Zhen Xiao
HG Huiming Guo
XF Xianhong Fang
JL Jingnan Liang
JZ Jiening Zhu
JY Jing Yang
HL Hui Li
RP Rong Pan
SY Shujing Yuan
WD Wenyan Dong
XZ Xi‐Long Zheng
SW Shulin Wu
ZS Zhixin Shan
request Request a Protocol
ask Ask a question
Favorite

Human atrial fibroblasts (HAFs) were isolated from atrial appendage tissue of patients with SR. The atrial appendage tissue was digested using 0.25% trypsin plus 20 IU/mL DNase. HAFs were separated from cardiomyocytes using gravity separation and then grown to confluency in 10‐cm cell culture dishes in the growth media (DMEM/LG 10% FBS, 1% penicillin and 1% streptomycin) at 37°C in humid air with 5% CO2. HAFs from the fourth to sixth passage were used for the experiments. The miR‐23b‐3p mimic, miR‐27b‐3p mimic and TGFBR3 siRNA (50 nmol/L each, RiboBio, Guangzhou, China) were transfected into HAFs using oligofectamine reagent (Invitrogen, Carlsbad, CA, USA). HAFs were then incubated with DMEM/LG 1% FBS overnight before treatment with 10 μmol/L Ang‐II (Sigma‐Aldrich, St. Louis, MO, USA). As indicated, HAFs were infected with the following recombinant adenovirus respectively: rAd‐GFP, rAd‐TGFBR3 adenovirus (MOI 5).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A